|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
The control of DNA integrity in mammalian cells is important to maintain the cell homeostasis and prevent neoplastic transformation. Control of cell division and cell death permits repair or elimination of damaged cells. Since asbestos fibers can produce DNA damage, chromosome alterations and apoptosis in several sorts of cells, including mesothelial cells, it was interesting to investigate cell cycle disturbances in rat
pleural mesothelial cells (RPMC) treated with asbestos fibers. Cell cycle analyses were performed in
RPMC exposed to crocidolite (10 and 20 µg/cm2 ) and chrysotile (5 and 10 µg/cm2 ) for different times (4 to 48 h). Both fiber types entailed a G2/M accumulation in agreement with a delay in the mitosis course. Chrysotile fibers produced a G0/G1 accumulation associated with a time-dependent p53 and p21 expression. Crocidolite exposure resulted in a delay in the G1/S transition paralleling a low rate of p53 expression. These results are in agreement with a DNA damaging potential of asbestos fibers since similar results
were found following RPMC exposure to
rays. In asbestos-treated RPMC, a low rate of apoptosis was
found suggesting that RPMC may follow a DNA repair pathway that could contribute to the formation of DNA lesions. In addition, the cell cycle disturbances at the G2/M checkpoint suggest that genetically altered cells have progressed through the cycle and support the already published findings on the ability of
asbestos fibers to impair cell division.
| |
Introduction |
|---|
|
|
|---|
Human exposure to asbestos fibers produces malignant mesothelioma, a primary tumor due to the neoplastic transformation of mesothelial cells. The interactions between mesothelial cells and asbestos fibers are complex and the mechanisms by which asbestos produce cell damage are still a matter of controversy. Mesothelial cells exposed to asbestos in vitro exhibit a wide range of molecular and cellular changes. These include the release of inflammatory factors (1, 2), the production of reactive oxygen derivatives, the induction of several genes (c-Fos, c-Jun, NFKappaB), DNA and chromosome damage (3) and neoplastic transformation (7). In previous studies, we found that asbestos induced a dose-dependent reduction in cell proliferation, as shown by an increase in the mean population doubling time (8). In terms of regulation of cell proliferation, this means that the cell cycle progression is blocked and /or that some cells are engaged in the cell death pathway. Since DNA damage, cell proliferation and cell death are important processes in carcinogenesis, it is of great importance to understand the molecular events associated with the cellular changes induced by asbestos fibers in mesothelial cells.
Several studies have reported that, in many cell types, alterations in cell cycle progression occur after exposure to DNA damaging agents. This is likely to permit DNA repair before the continuing of DNA synthesis or mitosis. Delays take place at both G1 and G2 phases of the cell cycle (9). Failure in repair processes could result in fixation and propagation of genomic changes necessary for neoplastic transformation. Under certain circumstances, DNA damage may trigger a rapid programmed death of the cells, apoptosis, a process that has already been described in asbestos-exposed mesothelial cells (10, 11). This cell death is a useful process for eliminating highly damaged cells and avoiding propagation of abnormalities. Conversely, disregulation of the cell response to apoptotic signals may be an important event in neoplastic transformation.
A critical regulator of the cellular response to genotoxic stress is the transcription factor encoded by the p53
tumor suppressor gene (12, 13). Several studies suggest
that the nuclear phosphoprotein p53 participates in the
control of cell cycle progression following certain types of
DNA damage; it could also be involved in the performance of some forms of apoptosis. Ionizing radiations,
UV radiations, or chemotherapy can increase the nuclear
p53 level (14). In many cell types, this increase correlates
temporarily with an arrest of the irradiated cells in the G1
phase of the cell cycle (15, 16) or in the G2 phase (17, 18).
Several experiments show that the wild type p53 protein
can stimulate the transcription of some crucial genes such
as the gene encoding for the p21/WAF1/CIP1, an inhibitor
for cyclin-dependent kinase (19, 20). By a direct interaction with several cyclins and cyclin-dependent kinases, this
protein inhibits the kinase activity and leads to a disruption of both initiation and progression through the S phase
and mitosis course (21, 22). The p21/WAF1/CIP1 protein
can also stop DNA synthesis by directly inhibiting some proteins involved in the replication machinery, such as the
Proliferating Cell Nuclear Antigen (PCNA), a DNA polymerase
auxilliary (23). P53 could be a determinant factor
between DNA repair and elimination of damaged cells.
Besides, the balance between DNA repair and apoptosis
seems to be a key point in the understanding of cancer induction. In the present study, we observed cell cycle progression of RPMC treated with asbestos fibers and also
determined the associated rate of apoptosis. We observed
cell cycle disruptions at G1 and G2 phases in response to asbestos exposure and a low apoptosis yield. These responses
correlated with the expression of p53 and p21 proteins.
| |
Materials and Methods |
|---|
|
|
|---|
Cells
Normal rat pleural mesothelial cells (RPMC) were obtained from rat parietal pleura according to a method described previously (24). They were cultured at 37°C in Ham's F10 medium (ATGC, Noisy le Grand, France) supplemented with 10% fetal bovine serum (FBS) (ATGC), 10 mM N-2-hydroxyethylpiperazine-N'-2-ethane sulfonic acid (Hepes) (Eurobio, Les Ulis, France), 100 IU/ml penicillin, 50 µg/ml streptomycin (Eurobio). Confluent monolayers were routinely subcultured by detachment with a mixture of 0.25% trypsin (Eurobio) + 0.02% EDTA (Merck, Nogent sur Marne, France). Only diploid cells and cultures not older than 25 passages were used in this study. In some experiments, rat pleural mesothelial cells infected with a retroviral recombinant large T-antigen of SV40 were used as a reference (TSV40-RPMC) for p53 expression in Western blots. These cells were cultured as described above in RPMI 1640 medium (ATGC) supplemented with the same constituants as Ham's F10 medium.
Reagents, Drugs, Particles and Antibodies
Camptothecin was purchased from Sigma (La Verpillière, France). A stock solution (1 mg /ml) was made and kept frozen in dimethylsulfoxide (DMSO) (Sigma). Two types of asbestos fibers obtained from the Union Internationale Contre le Cancer (UICC) were used: Rhodesian chrysotile and crocidolite. Mean length was 1.7 ± 2.2 µm and 2.1 ± 3.6 µm, respectively (25). Fibers (1 mg /ml) were dispersed by sonication in complete Ham's F10 medium for 5 min (50 watts; Vibra cell, BioBlock, Illkirch, France) to permit a homogenous suspension of the fibers.
A monoclonal antibody against human p53 protein (HR 231) was purchased from Eurobio. It cross-reacted with rat p53 and was specific of the wild type p53. It was used at a final concentration of 2 µg /ml. Polyclonal antibodies against bcl2 protein (N-19) and p21/WAF1/CIP1 protein (M-19) were purchased from TEBU (Le Perray en Yvelines, France) and were used at a final concentration of 0.1 µg /ml.
Treatments
All treatments were performed with log phase RPMC. Camptothecin was used as a reference for a p53-dependent cell cycle arrest and apoptosis induction (26). RPMC were treated for 1, 4, 24, 48 and 72 h with 10 µg /ml of camptothecin dissolved in DMSO. DMSO was added to control cell culture at the concentration used in the treated cells. This concentration never exceeded 1% and did not affect cell survival. Fibers were used at concentrations of 0 (untreated), 0.5, 2, 10 and 20 µg /cm2: 48 h after seeding, the medium was discarded and replaced with the same medium containing fibers for 1, 4, 24, 48 and 72 h.
RPMC were
-irradiated at a dose of 24 Gy (1.46 Gy/
min) by exposure to a 60Co source (Alcyon from General
Electric Medical System, France).
Cell Cycle Analysis
Cells were seeded in 75 cm2 flasks (Costar, Brumath, France) in 12 ml of complete Ham's F10 medium. Forty-eight hours after seeding, cells were treated as described above in 10 ml of medium. The study of cell cycle progression was performed according to the method of Dolbeare and associates (27). Asbestos- or camptothecin-treated cells were incubated in a medium containing 18 µg/ml of bromodeoxyuridine (BrdUrd) (Sigma) for different lengths of time. After fixation at 4°C in 70% ethanol, cells were washed and resuspended in 2 M HCl for 30 min at room temperature. After washing, cells were incubated with BrdUrd antibodies (Dako, Trappes, France) for 1 h at room temperature and then stained with propidium iodide for 1 h. Flow cytometry analysis was made with a Coulter (Margency, France) Epics XL W05039 cytometer. This method allows the determination of parameters representing the proportion of both cycling and noncycling cells, that is BrdUrd incorporated into cells in the S phase and, depending on the duration of BrdUrd incorporation and rate of cell progression, distributed into G2/M and G0/G1. Propidium iodide incorporation allows us to assign the cells to a 2N, 2N to 4N, or 4N compartment. Data were analyzed according to the Multicycle analysis software distributed by Coulter. Statistical analysis was performed using a variance analysis followed by a two-tailed Student's test. The percentages of treated and untreated cells in each population (replicative phase or G2/M phase) were compared.
Apoptosis Analysis
Analysis of DNA cleavage. Forty-eight hours after seed-ing in 75-cm2 flasks, cells were treated as described above in 10 ml of complete Ham's F10 medium. After different lengths of treatment, the cells were washed in PBS (Gibco, Cergy Pontoise, France), trypsinized, resuspended in STE buffer (NaCl: 0.1 M, Tris HCl: 10 mM, EDTA: 1 mM) with 0.1% SDS 10% and 200 µg/ml of proteinase K (Boehringer Mannheim, Meylan, France) and incubated for 3 h at 56°C. DNA was extracted with a phenol /isoamyl alcohol mixture (Fluka, Saint Quentin Fallavier, France) and precipitated at
20°C with ethanol and 3 M sodium acetate. The
DNA pellet was resuspended in TE buffer, pH = 7.4 (Tris
HCl: 10 mM, EDTA: 1 mM). The characterization of DNA
cleavage was then achieved by submitting the samples to
an electrophoresis on 1.5% agarose gel in TBE buffer (Tris
base: 2 M, Boric acid: 2 M, EDTA: 0.01 M).
Since DNA damage could occur following the incubation of asbestos fibers with DNA (28), we investigated
DNA stability in the presence of asbestos fibers by incubating 5 µg of salmon sperm DNA with 30, 125 or 1,000 µg /ml of fibers in TE buffer, at 37°C, i.e., under the same
conditions as for cell DNA extraction. After extraction, an
electrophoresis on 1.5% agarose gel was performed to determine whether strand breakage of DNA had occurred.
Furthermore, the low molecular weight DNA fragments
were loaded onto 1.5% agarose gel in presence of crocidolite fibers to determine whether the presence of fibers
would impair DNA migration. For this purpose, low molecular weight markers were incubated in TE buffer with fibers (30, 125 or 1,000 µg/ml) at 37°C for 48 h to mimic
the DNA migration conditions in asbestos-treated cells.
May Grünwald/Giemsa (MGG) staining.
RPMC were
seeded on 9 cm2 slide flasks (Costar, Brumath, France) in
3 ml of complete Ham's F10 medium. Forty-eight hours after seeding, cells were treated as described previously. After different lengths of time of treatment, cells were fixed
in methanol/acetic acid (3:1/vol:vol), stained in May Grünwald and in 3% Giemsa (CML, Nemours, France). Observation was made by light microscopy on 2,000 cells per
slide. Four slide flasks were analyzed per treatment. Statistical analysis was performed using a variance analysis followed by a two-tailed Student's test.
Viability Test: MTT
This test was performed according to Mosmann's method (29). Cells were seeded in 96-well cell culture plates (Costar) at a concentration of 7,000 cells/ml. When cells reached confluence, treatments with asbestos fibers were performed under the same conditions as for the other analyses. At the end of treatment, MTT (3-[4,5-dimethylthiazol-2-yl]- 2,5 diphenyl tetrazolium bromide) (Sigma) was added at a final concentration of 0.4 mg /ml and culture plates were incubated at 37°C for 3 h. The supernatant was then carefully removed and 200 µl of DMSO were added to dissolve the reduced MTT. The amount of reduced MTT was determined by the measurement of absorbance (A) at 540 nm. For each treatment, 8 wells were analyzed and 4 independent experiments were carried out. The results are expressed as loss of cell viability in comparison with the untreated control:
|
Statistical analysis was performed using a variance analysis followed by Student's t test.
Protein Extraction and Western Blotting
Western blot analysis was carried out on cytoplasmic and nuclear fractions as well as on total cell extracts.
Total protein extraction. After treatments, cells were washed with PBS and lysed by scraping in the lysis buffer: 1% NP40 (Nitrophenoxy 40, used as a detergent), 10 mM EDTA, 25 µM NPGB (pNitro-guanidinobenzoate), used as protease inhibitors, in PBS 1X. After an incubation on ice, cells were homogenized by using a loose fitting glass-teflon homogenizer and centrifuged at 16,000 × g for 15 min. Protein content was determined in the supernatant by Lowry's method (30) (Kit Biorad, Ivry/Seine, France). Nuclear and cytoplasmic protein extraction. After wash-ing in PBS, cells were scraped in a sucrose buffer (0.25 M sucrose, 3 mM imidazole, 1 mM EDTA) and then homogenized as described above. After centrifugation at 1,500 rpm for 15 min, the cytoplasmic protein content was determined in the supernatant. The pellet which contained nuclei and unbroken cells was resuspended in a lysis buffer and centrifuged at 12,000 × g, for 15 min prior to protein measurement. Electrophoretic procedures. Proteins (25-35 µg) were electrophoretically analyzed on a 10% (for p53 analysis) or 14% (for bcl2 and p21 studies) polyacrylamide discontinuous mini slab gels in a mini Protean II Cell (Bio-Rad). The electrophoretic transfer of proteins from SDS-PAGE slab gels onto nitrocellulose membrane (Schleicher et Schuell-Cera Labo, Ecqueville, France) was performed in a mini transblot cell (Bio-Rad) for 1 h on ice at 250 mA, according to the method described by Towbin and associates (31). Prestained molecular weight markers (Bio-Rad) were used to assess transfer efficiency and determine the size of blotted proteins. After transfer, the membrane was blocked 1 h at room temperature with 5% (wt/vol) skimmed milk in 0.05 M Tris buffer pH 7.4 containing 1 M PBS and 0.05% Tween-20 and then incubated with primary antibodies overnight at room temperature. Blots were developed using enhanced chemical luminescence (Amersham-Life Science, Les Ulis, France).| |
Results |
|---|
|
|
|---|
Cell Cycle Analysis
Cell cycle analysis was performed using a double labeling method with BrdUrd and propidium iodide. Kinetics of BrdUrd incorporation, from 30 min until 9 h, gave a dynamic view of the cycle progression. The dot plots allow the quantification of the replicating cells, i.e., cells incorporating BrdUrd. The quantification of the G2/M cells is based on the analysis of the propidium incorporation results. The cell cycle distribution of untreated RPMC was studied under the same experimental conditions as asbestos-treated cells, i.e., at times corresponding to 4, 24, and 48 h of treatment. The percentage of cells in the replicative phase in untreated cultures decreased with time, indicating that the cells progressed toward confluence (Table 1). At 48 h, 10% of the cells were in the replicative phase. The percentage of G2/M cells accordingly showed a time-depen-dent decrease (Table ).
|
Treatment with 10 µg /cm2 of chrysotile resulted in several disruptions of cell growth. Cell cycle analyses performed after 30 min of BrdUrd incorporation showed modifications suggesting disruptions in the cell cycle at two locations, G0/G1 and G2/M (Table ). An alteration of the G1/S progression is suggested by the significant reduction in the amount of cells entering the replicative phase in comparison with untreated cells. A time-dependent reduction in the percentage of replicating cells was observed in both untreated and asbestos-treated RPMC, but it was greater in chrysotile-treated cells (76% between 4 and 24 h) than in untreated cells (36%). After 48 h of contact with 10 µg/cm2 chrysotile, only 1.5% of the cells were engaged in the replicative phase. The microscopic observations illustrate that the decrease in the replicating cell population did not result from a confluent state in asbestos-treated cells. In contrast, the number of cells was much lower in asbestos-treated cells than in untreated cells as already described (8). To distinguish a cell cycle delay in G1/S transition and an arrest in the G1 phase, we increased the time of BrdUrd incorporation to 9 h. On that condition, if cells are only delayed in G1, they would further progress through G1/S. Thus, after 9 h, BrdUrd labeled cells would have been found. The dot plots presented in Figure 1 show that no BrdUrd labeled cells were detected after 48 h of treatment with chrysotile, confirming the induction of a blockade in the G1 phase.
|
Table shows that the percentage of cells in G2/M phase was enhanced following chrysotile exposure in comparison with that of untreated cells, suggesting that chrysotile fibers were able to induce a G2/M delay. G2/M accumulation was also observed on the dot plots (Figure 1A); it was associated with the appearance of cells with a DNA content greater than 4N. The microscopic observations indicated that this population corresponded to bi- or multinucleated cells (Figure 2).
|
In crocidolite-treated cultures, the proportion of replicating cells was slightly modified after 4 h of treatment in comparison with untreated cultures. A reduction in the percentage of cells in the replicative phase was observed, but it always remained lower than after chrysotile treatment. Moreover, it was attenuated with the length of treatment. When compared to untreated cells, the percentage of cells incorporating BrdUrd was reduced to 65, 76, and 97% after treatment with 10 µg /cm2 for 4, 24, and 48 h, respectively (Table ). The analysis of dot plots obtained after 9 h of BrdUrd incorporation (Figure 1B) showed that the cell cycle progression was not totally arrested. This suggests that crocidolite fibers induce a delay rather than an arrest in the transition between the G1 and S the phase. The propidium iodide incorporation data showed a time-dependent G2/M accumulation in crocidolite-treated cells. It was 1.3 and 3.2 times more than that of untreated cells after exposure to 10 µg /cm2 of crocidolite for 24 and 48 h respectively (Table ). The difference was significant after 48 h of treatment.
From data we previously obtained, the number of fibers in the chrysotile sample is 4 times higher than that of crocidolite: 22 × 106 versus 5.3 × 106 per µg, respectively. By comparing results obtained with 5 µg/cm2 (110 × 106 fibers/cm2) of chrysotile to those obtained with 20 µg/cm2 of crocidolite (106 × 106 fibers/cm2), we observed that even on a per number of fiber basis, the chrysotile sample presented a greater ability, in comparison with crocidolite, to induce cell cycle disturbances, especially at the G1/S transition.
Treatment with camptothecin for 24 h resulted in different modifications in the cell cycle since no G2/M accumulation was observed. The blockade of the cell cycle progression occurred at the G1/S transition, in agreement with results in the literature. A reduction in the percentage of cells incorporating BrdUrd was also found after camptothecin treatment in comparison with untreated cells.
In order to determine whether the cell cycle alterations
observed after asbestos exposure were of the same type as
those produced by reactive oxygen species, RPMC were
exposed to
irradiation. The cell cycle alterations occurring 24 h after
irradiation (Figure 1C) were similar to
those observed after chrysotile exposure, i.e., an arrest at
the G1/S transition and a cell accumulation in the G2/M
phases.
p53 Protein Induction
Since several studies have shown an association between a p53 up-regulation and cell cycle arrest (17, 32), it was interesting to determine whether the cell cycle alterations observed after asbestos exposure were accompanied by an increase in p53 expression. As shown in the typical experiment presented in Figure 3, Western blotting analyses of total protein extracts indicated that p53 protein was present in untreated cells but at a low level. Treatment of RPMC with asbestos fibers resulted in a time-dependent induction of p53: After 1 h of treatment with chrysotile (10 µg /cm2), the p53 level was the same as in untreated cells but an enhancement was detected after 24 and 48 h (Figure 3). Analysis of cytoplasmic and nuclear protein fractions allowed the localization of p53 in the nuclear fractions. The p53 level in cytoplasmic extracts was very low and did not change with the duration of treatment. After crocidolite treatment (Figure 3), p53 induction was lower than in chrysotile-treated cells. By immunocytochemistry, no nuclear p53 was detectable in asbestos-treated RPMC whereas UV irradiation induced a p53 nuclear localization (data not shown).
|
Treatment with camptothecin (Figure 3) also resulted in an increase in p53 expression. This p53 induction was observed from 1 h after treatment and increased in a time-dependent manner until 48 h of treatment.
In all experiments performed on total protein extracts, several extrabands appeared despite the use of a monoclonal antibody. Control experiments, performed with no primary antibody, have ensured the specificity of the p53 signal, since, under those conditions, no band appears in the molecular weight range of the p53 protein (data not shown). However, to be sure to detect the presence of the p53 protein even at a very low level, we have used a high antibody concentration that could partly explain the high background.
p21/WAF1/CIP1 Protein Expression
Several reports in the literature have associated the p53 protein induction with an increased level of the p21/ WAF1/CIP1 protein. Regarding the p53 upregulation after asbestos exposure, it was interesting to study the p21/ WAF1/CIP1 expression in asbestos-treated RPMC.
As shown in the typical experiment reported in Figure 4, it appeared that the p21 protein was expressed after 24 and 48 h of chrysotile treatment (10 µg /cm2), but not earlier. The time-course of the p21 protein expression following crocidolite treatment was slightly different: p21 protein was only detected after 48 h. For the shorter lengths of treatment, the p21 protein was not detected. In untreated cells, the p21 protein level was very low.
|
A time-dependent induction of p21 occurred in camptothecin-treated RPMC (Figure 4). After 1 h, the level of p21 expression was the same as in control cells but after 4 h of treatment, the protein expression increased until 24 h and remained stable.
Analysis of RPMC Viability and Apoptosis
Analysis of RPMC viability performed with the MTT assay shows a decrease in cell viability in comparison with untreated controls (Figure 5). On a per weight basis, chrysotile was more cytotoxic than crocidolite. The maximal loss in cell viability in RPMC treated with chrysotile reached 60% whereas it did not exceed 40% with crocidolite. Moreover, cytotoxicity appeared later after the treatment with crocidolite than with chrysotile (after 1 h and 4 h, respectively). In RPMC treated with chrysotile fibers, cytotoxicity was time- and dose-dependent whereas increasing concentrations of crocidolite above 2 µg /cm2 did not significantly enhance its effect. RPMC viability was greatly impaired with 10 µg /ml of camptothecin (74% loss of cell viability after 72 h of treatment).
|
To determine to what extent loss of cell viability was due to apoptosis, we quantified the number of apoptotic cells induced by the different treatments, by morphological observation following MGG staining. The spontaneous rate of apoptosis observed in untreated cultures was 0.05% and 0.1% after 24 and 48 h of culture, respectively. Chrysotile fibers induced a dose-dependent apoptosis in RPMC. The highest percentage of apoptotic cells (4%) was observed after 72 h of treatment with 10 µg /cm2 of chrysotile. Apoptosis, in cells treated with crocidolite, appeared at the highest concentrations tested and at a low rate (lower than 1%) (Figure 6). As expected, camptothecin, used as a positive control, triggered a rapid apoptosis in RPMC. Apoptosis was also detected by DNA fragmentation analysis, with the appearance of a DNA ladder in cultures treated with fibers and with camptothecin (Figure 7) not observed in experimental controls (Figure 8).
|
|
|
Bcl2 Protein Expression
The mitochondrial bcl2 protein is thought to be involved in the control of programmed cell death; it was therefore interesting to study the bcl2 protein expression during asbestos treatment. Figure 9 presents the results obtained after chrysotile asbestos and camptothecin treatment. No modification of the bcl2 protein was detected after the different lengths of treatment with 10 µg /cm2 of chrysotile, when compared with untreated cells. The same results were observed after camptothecin treatment.
|
| |
Discussion |
|---|
|
|
|---|
In the present study, we investigated cell cycle progression in asbestos-treated cells. We found that asbestos treatment provoked complex changes in cell cycle progression occurring in both G1/S and G2/M locations. Chrysotile exposure led to a time-dependent decrease in the percentage of cells in the replicative phase appearing after 4 h of treatment and persisting later. Results obtained after 9 h of BrdUrd incorporation showed that RPMC accumulated in G0/G1 after 24 h of treatment and were further unable to enter the replicative phase. These data suggest that chrysotile can induce a blockade in G0/G1. Crocidolite also limited the cell cycle progression after 4 h and 24 h of treatment, in agreement with a G1 arrest. However, the decrease in the percentage of cells in the replicative phase was moderate after 48 h. These results suggest that crocidolite delayed the cell cycle progression rather than provoking a blockade through G1/S progression.
The second evident disruption observed after asbestos exposure was localized at the G2/M checkpoint: an evident cell accumulation in G2/M phases occurred after 4 and 24 h of treatment with chrysotile and crocidolite, respectively. The formation of bi- or multinucleated cells after both treatments showed that the G2/M accumulation may not entirely reflect a G2 arrest. It may be due, at least partly, to the alteration of mitosis, especially to chromosome segregation, as demonstrated in several studies (33, 34). Bi- and multinucleated cells have also been found following treatment of human mesothelial cells with asbestos (35). Several studies have suggested that, in many cell types, a spindle checkpoint exists to ensure the maintenance of diploidy (36). Therefore, our results suggest that asbestos fibers might impair the spindle checkpoint.
The commonly held view on growth arrest at the G1/S
and G2/M transition points proposes that DNA damaged
cells stop their cell cycle progression to allow DNA repair
before entering either the replicative phase or mitosis (37).
Clopton and colleagues (38) demonstrated that CHO cells
respond to a low level of oxidative stress by a G1/S and a
G2/M arrest. For Hawn and associates (39), a G2/M arrest
is a hallmark of treatment with DNA damaging agents such as
irradiation (via the production of oxygen species) or agents that induce base mispairings. The results we
obtained after RPMC exposure to
irradiation for 24 h
were similar to those obtained with chrysotile fibers and
support this hypothesis. Therefore, the results obtained
with asbestos could be related to the fibers' ability to induce such DNA damage, via the generation of reactive oxygen species. Furthermore, for Seychab and colleagues
(40), the severity of the cell cycle disturbance (delay or arrest) may be dependent on the degree of DNA repair. Accordingly, the differences in cell cycle disruptions between
chrysotile and crocidolite might reflect differences in
DNA damage induction.
In order to study the mechanisms involved in cell cycle alterations, we investigated the expression of the tumor suppressor gene product p53 which would be a determinant factor in cell cycle control. While p53 is recognized as playing a role in the control of G1/S transition, its involvement at the G2/M checkpoint is at present debatable and the role of the protein may be dependent on cell type or on experimental conditions. Cross and associates (36) proposed that p53 is involved in the G2/M checkpoint control and observed that p53 defective cells develop a tetraploid population after treatment with spindle interacting agents. Under our conditions, an association between p53 induction and G2 delay is not evident. The accumulation of cells in the G2/M phase appeared clearly after 4 h of chrysotile exposure whereas no p53 accumulation was detectable. In contrast, a correlation between G1/S arrest and p53 expression exists: after chrysotile exposure, a clear limitation in G1/S transition after 48 h was associated with an increased p53 level that persisted after 48 h. In agreement with several reports (19, 41), this G0/G1 arrest seems to be mediated by the p53-dependent transcription of the p21/ WAF1/CIP1 since a coexpression of p21 protein and p53 appeared after treatment with chrysotile. The delay in G1/S transition observed after crocidolite exposure correlates with the low level of p53 expression and the absence of p21 expression. The results obtained with camptothecin clearly show that the irreversible G0/G1 arrest, observed after 24 h of treatment, was associated with both p53 and p21 accumulation, in agreement with other studies (26).
Cell cycle disruptions are associated with apoptosis induction as shown in several studies (42, 43). We therefore investigated apoptosis induced by asbestos fibers in the present study. A global analysis of DNA has demonstrated a DNA fragmentation characteristic of apoptosis. The apoptosis yield was determined after MGG staining; it did not exceed 4%. A very low rate of spontaneous apoptosis occurred in untreated RPMC (0.05% to 0.1% after 24 or 48 h of culture). After asbestos exposure, a time- and dose-dependent enhancement of apoptosis was found. In our experiment, the higher potential of chrysotile to induce apoptosis is in agreement with the MTT results demonstrating a higher loss of cell viability after chrysotile treatment than after crocidolite exposure. Apoptosis induction after asbestos exposure has already been reported by others (10, 11) but the level of apoptosis found in the present study was lower than that reported in those studies. Several parameters could account for the differences. First, the origin of asbestos samples was different (NIEHS versus UICC in the present study) that is, each mean sample length differs from another (11.4 µm for NIEHS crocidolite versus 2.1 µm for UICC crocidolite). Regarding the greater effect of long fibers in comparison with short fibers in asbestos cytotoxicity, the differences in fiber dimensions could account for the different results obtained. Second, the culture conditions were not identical in the different studies. In the study performed by Bérubé and colleagues (10), mesothelial cells were serum deprived for 24 h prior to fiber exposure, a condition known to enhance apoptosis in many cell systems (44, 45). In the Broaddus study (11), the cells were cultured in a serum-free medium for one hour before fiber treatment. The differences between our study and others are unlikely to be due to loss of apoptotic cells because we collected all the cells in suspension in the medium and our methodology allowed us to detect a high percentage of apoptotic cells after camptothecin treatment. The finding of cell cycle disturbances not associated with a high amount of apoptosis suggests that the amount of DNA damage permits DNA repair. It would be interesting to investigate the balance between apoptosis and repair of damage, because the proliferation of unrepaired or misrepaired cells might be of worse prognosis than the formation of apoptotic cells. Stimulation of lung and mesothelial cell proliferation has been reported within days after in vivo exposure of rodents to fibers (46).
The increase in p53 protein expression, associated with a nuclear localization, found in asbestos-treated RPMC parallels the appearance of apoptotic cells. Following crocidolite treatment, p53 induction was lower than after chrysotile treatment, in agreement with the lower rate of apoptosis. Thus, the apoptotic process observed in RPMC after asbestos treatment appears to be associated with a p53 induction. The data obtained with camptothecin are in agreement with this association. These results suggest that both apoptosis and p53 induction are directly dependent on the agent's ability to induce DNA damage. Another candidate that may be responsible for the cell commitment to apoptosis is the mitochondrial bcl2 protein. Many reports have demonstrated that in some cell lines, an enforced bcl2 expression can block p53-induced apoptosis (50, 51). On the other hand, a downregulation of bcl2 expression, for instance, after growth factor withdrawal, can be responsible for the increased tendency of some cell lines to undergo a p53-mediated apoptosis (52). In our study, no change in the bcl2 protein was found after treatment with chrysotile.
In conclusion, our results demonstrate that asbestos fibers behave as known DNA damaging agents (camptothecin,
irradiation) by inducing cell cycle disruptions associated with a low rate of apoptosis. This may suggest that the
DNA repair pathway can be preferentially chosen and
could therefore contribute to the fixation of DNA lesions.
Furthermore, the cell cycle alterations indicate that asbestos fibers might impair some cell cycle checkpoints, critical
to maintaining the genome integrity.
| |
Footnotes |
|---|
Address correspondence to: M. C. Jaurand. INSERM U 139, IM3. Faculté de Médecine, 8 rue du Général Sarrail, Créteil 94010, France. E-mail: jaurand{at}im3.inserm.fr
(Received in original form November 25, 1996 and in revised form March 20, 1997).
Acknowledgments: This work has been supported by INSERM funds and MRE grant No. 92CO741. The authors thank Thierry Soussy for providing the p53 antibody and Pascal Piedbois and Jean-Pierre Mège for cell irradiation.
Abbreviations BrdUrd, 5-bromo-2'-deoxyuridine; MGG, May Grünwald/Giemsa; RPMC, Rat pleural mesothelial cells; T SV40, SV 40 large T antigen.
| |
References |
|---|
|
|
|---|
1. Antony, V. B., C. L. Owen, and K. J. Garcia. 1989. Pleural mesothelial cells stimulated by asbestos release chemotactic activity for neutrophils in vitro. Am. Rev. Respir. Dis. 139: 199-206 [Medline].
2. Hott, J. W., J. A. Sparks, S. W. Godbey, and V. B. Antony. 1992. Mesothelial cell response to pleural injury- thrombin-induced proliferation and chemotaxis of rat pleural mesothelial cells. Am. J. Respir. Cell Mol. Biol. 6: 421-425 .
3. Yegles, M., L. Saint-Etienne, A. Renier, X. Janson, and M. C. Jaurand. 1993. Induction of metaphase and anaphase/telophase abnormalities by asbestos fibers in rat pleural mesothelial cells in vitro. Am. J. Respir. Cell Mol. Biol. 9: 186-191 .
4.
Dong, H. Y.,
A. Buard,
F. Levy,
A. Renier,
L. Saint-Etienne, and
M. C. Jaurand.
1994.
Role of oxygen derivatives in the cytotoxicity and DNA damage produced by asbestos on rat pleural mesothelial cells, in vivo.
Carcinogenesis
15:
1251-1255
5. Janssen, Y. M. W., N. H. Heintz, J. P. Marsh, P. J. A. Bormand, and B. T. Mossman. 1994. Induction of c-fos and c-jun proto-oncogenes in target cells of the lung and pleura by carcinogenic fibers. Am. J. Respir. Cell Mol. Biol. 11: 522-530 [Abstract].
6. Janssen, Y. M. W., J. P. Marsh, M. P. Absher, E. Gabrielson, P. J. A. Borm, K. Driscoll, and B. T. Mossman. 1994. Oxidant stress responses in human pleural mesothelial cells exposed to asbestos. Am. J. Respir. Crit. Care Med. 149: 795-802 [Abstract].
7. Jaurand, M. C., and J. C. Barrett. 1994. Neoplastic transformation of mesothelial cells. In The Mesothelial Cell and Mesothelioma. Marcel Dekker, Inc., New York. 207-221.
8. Jaurand, M. C., I. Bastie-Sigeac, J. Bignon, and P. Stoebner. 1983. Effect of chrysotile and crocidolite on the morphology and growth of rat pleural mesothelial cells. Environ. Res. 30: 255-269 [Medline].
9. Murname, J. P.. 1995. Cell regulation in response to DNA damage in mammalian cells: an historical perspective. Cancer Metastasis Rev. 14: 17-29 [Medline].
10. Bérubé, K. A., T. R. Quinlan, H. Fung, J. Magae, P. Vacek, D. J. Taatjes, and B. T. Mossman. 1996. Apoptosis is observed in mesothelial cells after exposure to crocidolite asbestos. Am. J. Respir. Cell Mol. Biol. 15: 141-147 [Abstract].
11. Broaddus, V. C., L. Yang, L. M. Scavo, J. D. Ernst, and A. M. Boylan. 1996. Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species. J. Clin. Invest. 98: 2050-2059 [Medline].
12. Götz, C., and M. Montenahr. 1993. P53: DNA damage, DNA repair and apoptosis. Rev. Physiol. Biochem. Pharmacol. 127: 65-95 .
13. Hainaut, P.. 1995. The tumor suppressor protein p53: a receptor to genotoxic stress that controls cell growth and survival. Curr. Opin. Oncol. 7: 76-82 [Medline].
14. Fritsche, M., C. Haessler, and G. Bradner. 1993. Induction of nuclear accumulation of the tumor suppressor protein p53 by DNA damaging agents. Oncogene 8: 307-318 [Medline].
15.
Kuerbitz, S. J.,
S. Plunkette,
W. V. Walsh, and
M. B. Kastan.
1992.
Wild type p53 is a cell cycle checkpoint determinant following irradiation.
Proc.
Natl. Acad. Sci. USA
89:
7491-7495
16.
Zhan, Q.,
F. Carrier, and
A. J. Fornace Jr..
1993.
Induction of cellular p53
activity by DNA-damaging agents and growth arrest.
Mol. Cell Biol.
13:
4242-4250
17. Stewart, N., G. G. Hicks, F. Paraskevas, and M. Mowat. 1995. Evidence for a second cell cycle block at G2/M by p53. Oncogene 10: 109-115 [Medline].
18. Guillouf, C., F. Rosselli, K. Krishnaraju, E. Moustacchi, B. Hoffman, and D. A. Liebermann. 1995. P53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis. Oncogene 10: 2263-2270 [Medline].
19.
El Deiry, W. S., J. W. Harper, P. M. O'Connor, V. E. Velculescu, C. E. Canman, J. Jackman, J. A. Pietenpol, M. Burrell, D. E. Hill, Y. Wang, K. G. Wiman, W. E. Mercer, M. B. Kastan, K. W. Kohn, S. J. Elledge, K. W. Kinzler, and B. Vogelstein.
1994.
WAF1/CIP1 is induced in p53-mediated
G1 arrest and apoptosis.
Cancer Res.
54:
1169-1174
20. Gudas, J., H. Nguyen, T. Li, D. Hill, and K. H. Cowan. 1995. Effects of cell cycle, wild-type p53 and DNA damage on p21 CIP1/Waf1 expression in human breast epithelial cells. Oncogene 11: 253-261 [Medline].
21. Brugarolas, J., C. Chandrasekaran, J. I. Gordon, D. Beach, T. Jacks, and G. J. Hannon. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552-557 [Medline].
22. Nakanishi, M., R. S. Robertorye, G. R. Adami, O. M. Pereira-Smith, and J. R. Smith. 1995. Identification of the DNA synthesis inhibitory gene p21Sdi1/CIP1/WAF1. EMBO J. 14: 555-563 [Medline].
23. Li, R., S. Waga, G. J. Hannon, D. Beach, and B. Stillman. 1994. Differential effects by the p21 cdk inhibitor on PCNA-dependent DNA replication and repair. Nature 371: 534-537 [Medline].
24. Jaurand, M. C., J. F. Bernaudin, A. Renier, H. Kaplan, and J. Bignon. 1981. Rat pleural mesothelial cells in culture. In Vitro 17: 98-106 [Medline].
25.
Yegles, M.,
X. Janson,
H. Y. Dong,
A. Renier, and
M. C. Jaurand.
1995.
Role of fibers characteristics on cytotoxicity and induction of anaphase/telophase aberrations on rat pleural mesothelial cells in vitro: correlations
with in vivo animal findings.
Carcinogenesis
16:
2751-2758
26.
Chen, X.,
J. Bargonetti, and
C. Prives.
1995.
P53, through p21 (WAF1/
CIP1), induces cyclin D1 synthesis.
Cancer Res.
55:
4257-4263
27.
Dolbeare, F.,
H. Gratzner,
M. Pallavicini, and
J. W. Gray.
1983.
Flow cytometric measurements of total DNA content and incorporated BrdUrd.
Proc. Natl. Acad. Sci. USA
80:
5573-5577
28.
Lund, L. G., and
A. E. Aust.
1992.
Iron mobilization from crocidolite asbestos greatly enhances crocidolite-dependent formation of DNA single-strand breaks in
X174 RFI DNA.
Carcinogenesis
13:
637-642
29. Mosmann, T.. 1983. Rapid colorimetric assay for cellular growth and survival; applications to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63 [Medline].
30.
Lowry, O. H.,
N. J. Rosebrough,
A. L. Farr, and
R. J. Randall.
1951.
Protein measurement with the folin phenol reagent.
J. Biol. Chem.
193:
265-275
31.
Towbin, H.,
T. Staehelin, and
J. Gordon.
1979.
Electrophoretic transfer of
proteins from polyacrylamide gels to nitrocellulose sheets: procedure of
some applications.
Proc. Natl. Acad. Sci. USA
76:
4350-4354
32.
Lin, D.,
M. T. Shields,
S. J. Ullrich,
E. Appella, and
W. E. Mercer.
1992.
Growth arrest induced by wild type p53 protein blocks cells prior to or
near the restriction point in late G 1 phase.
Proc. Natl. Acad. Sci. USA
89:
9210-9214
33.
Hesterberg, T. W., and
J. C. Barrett.
1985.
Induction by asbestos fibers of
anaphase abnormalities: mechanism for aneuploidy induction and possibly
carcinogenesis.
Carcinogenesis
6:
473-475
34. Dopp, E., J. Saedler, H. Stopper, D. G. Weiss, and D. Schiffmann. 1995. Mitotic disturbances and micronucleus induction in syrian hamster embryo fibroblast cells caused by asbestos fibers. Environ. Health Perspect. 103: 268-271 [Medline].
35. Pélin, K., K. Husgafvelpursiainen, M. Vallas, E. Vanhala, and K. Linnainmaa. 1992. Cytotoxicity and anaphase aberrations induced by mineral fibers in cultured human mesothelial cells. Toxicol. In Vitro 6: 445-450 .
36.
Cross, S. M.,
C. A. Sanchez,
C. A. Morgan,
M. K. Schimke,
S. Ramel,
R. L. Idzerda,
W. H. Raskind, and
B. J. Reid.
1995.
A p53-dependent mouse
spindle checkpoint.
Science
267:
1353-1356
37. Kaufmann, W. K.. 1995. Cell cycle checkpoints and DNA repair preserve the stability of human genome. Cancer Metastasis Rev. 14: 31-41 [Medline].
38. Clopton, D. A., and P. Saltman. 1995. Low level oxidative stress cause cell cycle specific arrest in cultured cells. Biochem. Biophys. Res. Commun. 210: 189-196 [Medline].
39.
Hawn, M. T.,
A. Umar,
J. M. Carethers,
G. Marra,
T. A. Kunkel,
C. Richard,
Boland, and
M. Koi.
1995.
Evidence for connection between the mismatch
repair system and the G2 cell cycle checkpoint.
Cancer Res.
55:
3721-3725
40. Seyschab, H., Y. Sun, R. Friedl, D. Schindler, and H. Hoehn. 1993. G2 phase cell cycle disturbance as a manifestation of genetic cell damage. Hum. Genet. 92: 61-68 [Medline].
41.
Bae, I.,
S. Fan,
K. Bhatia,
K. W. Kohn,
A. J. Fornace Jr., and
P. M. O'Connor.
1995.
Relationships between G1 arrest and stability of the p53 and
p21 Cip1/ Waf1 proteins following
irradiation of human lymphoma cells.
Cancer Res.
55:
2387-2393
42. Allday, M. J., G. J. Inman, D. H. Crawford, and P. J. Farrell. 1995. DNA damage in human B cells can induce apoptosis, proceeding from G1/S when p53 is transactivation competent and G2/M when it is transactivation defective. EMBO J. 14: 4994-5005 [Medline].
43. Kondo, S.. 1995. Apoptosis by antitumor agents and other factors in relation to cell cycle checkpoints. J. Radiat. Res. 36: 56-62 .
44. Wyllie, A. H.. 1995. The genetic regulation of apoptosis. Curr. Opin. Genet. Dev. 5: 97-104 [Medline].
45.
Preston, G. A.,
J. E. Lang,
R. R. Maronpot, and
J. C. Barrett.
1994.
Regulation of apoptosis by low serum in cells of different stages of neoplastic progression: enhanced susceptibility after loss of a senescence gene and decreased susceptibility after loss of a tumor suppressor gene.
Cancer Res.
54:
4214-4223
46. McGravan, P. D., and A. R. Brody. 1989. Chrysotile inhalation induces tritiated thymidine incorporation by epithelial cells of distal brochioles. Am. J. Respir. Cell Mol. Biol. 1: 231-235 .
47. Adamson, I. Y. R., J. Bakowska, and D. H. Bowden. 1993. Mesothelial cell proliferation after instillation of long or short asbestos fibers into mouse lung. Am. J. Pathol. 142: 1209-1216 [Abstract].
48. Donaldson, K., D. M. Brown, B. G. Miller, and A. R. Brody. 1995. Bromo-deoxyuridine (BRDU) uptake in the lungs of rats inhaling amosite asbestos or vitreous fibers at equal airborne fiber concentrations. Exp. Toxicol. Pathol. 47: 207-211 [Medline].
49. Moalli, P. A., J. L. Macdonald, L. A. Goodlick, and A. B. Kane. 1987. Acute injury and regeneration of the mesothelium in response to asbestos fibers. Am. J. Pathol. 128: 426-445 [Abstract].
50.
Dole, M.,
G. Nunez,
A. K. Merchant,
J. Maybaum,
C. K. Rode,
C. A. Bloch, and
V. P. Castle.
1994.
Bcl-2 inhibits chemotherapy-induced apoptosis in
neuroblastoma.
Cancer Res.
54:
3253-3259
51.
Chiou, S. K.,
L. Rao, and
E. White.
1994.
Bcl-2 blocks p53 dependent apoptosis.
Mol. Cell Biol.
14:
2556-2563
52.
Miyashita, T.,
M. Harigai,
M. Hanada, and
J. C. Reed.
1994.
Identification
of a p53-dependent negative response element in the Bcl2 gene.
Cancer Res.
54:
3131-3135
This article has been cited by other articles:
![]() |
V. Panduri, S. Surapureddi, S. Soberanes, S. A. Weitzman, N. Chandel, and D. W. Kamp P53 Mediates Amosite Asbestos-Induced Alveolar Epithelial Cell Mitochondria-Regulated Apoptosis Am. J. Respir. Cell Mol. Biol., April 1, 2006; 34(4): 443 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Upadhyay and D. W. Kamp Asbestos-Induced Pulmonary Toxicity: Role of DNA Damage and Apoptosis Experimental Biology and Medicine, June 1, 2003; 228(6): 650 - 659. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cacciotti, R. Libener, P. Betta, F. Martini, C. Porta, A. Procopio, L. Strizzi, L. Penengo, M. Tognon, L. Mutti, et al. SV40 replication in human mesothelial cells induces HGF/Met receptor activation: A model for viral-related carcinogenesis of human malignant mesothelioma PNAS, September 19, 2001; (2001) 211026798. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Liu, J. D. Ernst, and V. Courtney Broaddus Phagocytosis of Crocidolite Asbestos Induces Oxidative Stress, DNA Damage, and Apoptosis in Mesothelial Cells Am. J. Respir. Cell Mol. Biol., September 1, 2000; 23(3): 371 - 378. [Abstract] [Full Text] |
||||
![]() |
V. Levresse, A. Renier, F. Levy, V.C. Broaddus, and M.-C. Jaurand DNA breakage in asbestos-treated normal and transformed (TSV40) rat pleural mesothelial cells Mutagenesis, May 1, 2000; 15(3): 239 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W Kamp and S. A Weitzman The molecular basis of asbestos induced lung injury Thorax, July 1, 1999; 54(7): 638 - 652. [Full Text] |
||||
![]() |
L. Xu, B. J. Flynn, S. Ungar, H. I. Pass, K. Linnainmaa, K. Mattson, and B. I. Gerwin Asbestos induction of extended lifespan in normal human mesothelial cells: interindividual susceptibility and SV40 T antigen Carcinogenesis, May 1, 1999; 20(5): 773 - 783. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Courtney Broaddus Asbestos, the Mesothelial Cell and Malignancy: A Matter of Life or Death Am. J. Respir. Cell Mol. Biol., December 1, 1997; 17(6): 657 - 659. [Full Text] |
||||
![]() |
P. Cacciotti, R. Libener, P. Betta, F. Martini, C. Porta, A. Procopio, L. Strizzi, L. Penengo, M. Tognon, L. Mutti, et al. SV40 replication in human mesothelial cells induces HGF/Met receptor activation: A model for viral-related carcinogenesis of human malignant mesothelioma PNAS, October 9, 2001; 98(21): 12032 - 12037. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |